Commission Implementing Decision (EU) 2016/2050
of 22 November 2016
as regards the placing on the market of a genetically modified carnation (Dianthus caryophyllus L., line SHD-27531-4)
(notified under document C(2016) 7443)
(Only the Dutch text is authentic)
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC1, and in particular the first subparagraph of Article 18(1) thereof,
After consulting the European Food Safety Authority,
Whereas:
Pursuant to Directive 2001/18/EC the placing on the market of a product containing or consisting of a genetically modified organism or a combination of genetically modified organisms is subject to a written consent being granted by the competent authority of the Member State that received the notification for the placing on the market of that product.
In March of 2013 a notification concerning the placing on the market of a genetically modified carnation (Dianthus caryophyllus L., line SHD-27531-4) was submitted by Suntory Holdings Limited, Osaka, Japan, to the competent authority of the Netherlands.
The notification covers import, distribution and retailing of genetically modified carnation Dianthus caryophyllus L., line SHD-27531-4.
In accordance with Article 14 of Directive 2001/18/EC, the competent authority of the Netherlands prepared an assessment report, which concluded that there are no reasons on the basis of which consent for the placing on the market of cut flowers of the genetically modified carnation (Dianthus caryophyllus L., line SHD-27531-4) for ornamental use should be withheld, if specific conditions are fulfilled.
The assessment report was submitted to the Commission and the competent authorities of the other Member States, some of which raised and one maintained objections to the placing on the market of the product.
In its opinion of 10 November 2014, the European Food Safety Authority (EFSA), addressed the objections maintained by a Member State and concluded that, should the propagation of genetically modified carnation SHD-27531-4 (e.g. rooting) by individuals occur, genetically modified carnation would not show any potential for increased survival, fitness or weediness compared with its parental line2. It also concluded that the potential spread of pollen of the genetically modified carnation by Lepidoptera to wild Dianthus species is highly unlikely to occur and, if it did occur, it is very unlikely that viable hybrids would be produced, survive and result in adverse environmental effects. Finally, it concluded that plant-to-plant gene transfer of the introduced genes is very unlikely and, if it did occur, it is unlikely to result in viable seed production leading to adverse environmental effects.
Following a request from the Commission to have a full EFSA opinion, on 15 December 2015, EFSA published a new opinion which concluded that there is no scientific reason to consider that import, distribution and retailing in the Union of genetically modified carnation SHD-27531-4 cut flowers for ornamental use will cause any adverse effect on human health or the environment3. EFSA also found that the monitoring plan provided by the consent holder was acceptable in the light of the intended uses of the genetically modified carnation.
An examination of the full notification, additional information provided by the notifier, specific objections maintained by a Member State in the light of Directive 2001/18/EC, and the opinions of EFSA, discloses no reason to believe that the placing on the market of cut flowers of the genetically modified carnation (Dianthus caryophyllus L., line SHD-27531-4) will adversely affect human health or the environment in the context of its proposed ornamental use.
A unique identifier has been assigned to the genetically modified carnation (Dianthus caryophyllus L., line SHD-27531-4) for the purposes of Regulation (EC) No 1830/2003 of the European Parliament and of the Council4 and Commission Regulation (EC) No 65/20045.
In light of the EFSA opinions, it is not necessary to establish specific conditions for the intended use with regard to handling or packaging of the product and the protection of particular ecosystems, environments or geographical areas.
The labelling of the product should include information that cut flowers of genetically modified carnation (Dianthus caryophyllus L., line SHD-27531-4) may not be used for human or animal consumption nor for cultivation.
A detection method was validated in March 2016 for the genetically modified carnation (Dianthus caryophyllus L., line SHD-27531-4) by the European Union Reference Laboratory established by Regulation (EC) No 1829/2003 of the European Parliament and of the Council6.
The Committee set up under Article 30(1) of Directive 2001/18/EC has not delivered an opinion within the time limit laid down by its Chairman. An implementing act was deemed to be necessary and the chair submitted the draft implementing act to the appeal committee for further deliberation. The appeal committee did not deliver an opinion,
HAS ADOPTED THIS DECISION:
Article 1Consent
1
Written consent shall be granted by the competent authority of the Netherlands to the placing on the market of genetically modified carnation (Dianthus caryophyllus L., line SHD-27531-4) notified by Suntory Holdings Limited, Osaka, Japan (Reference C/NL/13/01) and defined in Article 2.
2
The consent shall be given in writing and shall explicitly specify the requirements set out in Articles 3 and 4 and the unique identifier set out in Article 2(2).
3
The consent shall be limited to the placing on the market of cut flowers of the genetically modified carnation as a product.
4
The consent shall cover progeny derived through vegetative reproduction of the genetically modified carnation.
5
The period of validity of the consent shall be 10 years starting from the date on which the consent is issued.
Article 2Product
1
The genetically modified organism to be placed on the market, is a carnation (Dianthus caryophyllus L.) with modified flower colour, derived from a Dianthus caryophyllus L. cell culture, and transformed with Agrobacterium tumefaciens, strain AGL0, using the vector pCGP1991, and resulting in line SHD-27531-4.
The genetically modified carnation contains the following DNA in three cassettes:
a
Cassette 1
The petunia dfr gene encoding dihydroflavonol 4-reductase (DFR), a key enzyme in the anthocyanin biosynthetic pathway, including its own promoter and terminator.
b
Cassette 2
The promoter sequence from snapdragon chalcone synthase gene, flavonoid 3′5′-hydroxylase (f3′5′h) from Viola hortensis cDNA encoding F3′5′H, a key enzyme in the anthocyanin biosynthetic pathway, and the terminator from the D8 petunia gene encoding a putative phospholipid transfer protein.
These two cassettes were inserted into the plant genome to obtain the desired flower colour.
c
Cassette 3
The Cauliflower mosaic virus 35S promoter, the 5′-untranslated region from the petunia gene encoding chlorophyll a/b binding protein, the SuRB (als) gene coding for a mutant acetolactate synthase protein (ALS) derived from Nicotiana tabacum, which confers tolerance to sulfonylurea, including its own terminator. This trait was used as a marker in the selection of transformants.
2
The unique identifier of the genetically modified carnation shall be SHD-27531-4.
Article 3Conditions for placing on the market
The genetically modified carnation may be placed on the market subject to the following conditions:
- (a)
the genetically modified carnation may only be used for ornamental purposes;
- (b)
the cultivation of the genetically modified carnation shall not be allowed;
- (c)
without prejudice to confidentiality requirements set out in Article 25 of Directive 2001/18/EC, the methodology for detecting and identifying the genetically modified carnation, including experimental data demonstrating the specificity of the methodology, as validated by the European Union Reference Laboratory is publicly available at http://gmo-crl.jrc.ec.europa.eu/valid-2001-18.htm;
- (d)
without prejudice to the confidentiality requirements set out in Article 25 of Directive 2001/18/EC, the consent holder shall, whenever requested to do so, make positive and negative control samples of the product, or its genetic material, or reference materials available to the competent authorities and to inspection services of Member States as well as to Union control laboratories;
- (e)
the words ‘This product is a genetically modified organism’ or ‘This product is a genetically modified carnation’, and the words ‘not for human or animal consumption nor for cultivation’ shall appear either on a label or in a document accompanying the genetically modified carnations.
Article 4Monitoring
1
Throughout the period of validity of the consent, the consent holder shall ensure that the monitoring plan, contained in the notification and consisting of a general surveillance plan to check for any adverse effects on human health or the environment arising from handling or use of the genetically modified carnation, is put in place and implemented.
The monitoring plan is available at [Link: plan published on the internet].
2
The consent holder shall directly inform the operators and users concerning the safety and general characteristics of the genetically modified carnation and of the conditions as to monitoring, including the appropriate management measures to be taken in case of accidental cultivation.
3
The consent holder shall submit to the Commission and to the competent authorities of the Member States annual reports on the results of the monitoring activities.
4
The consent holder shall be in the position to give evidence to the Commission and the competent authorities of the Member States:
a
that the existing monitoring networks, including national botanic survey networks and plant protection services, as specified in the monitoring plan contained in the notification, gather the information relevant for the monitoring of the genetically modified carnation; and
b
that these existing monitoring networks referred to in point (a) have agreed to make available that information to the consent holder before the date of submission of the monitoring reports to the Commission and competent authorities of the Member States in accordance with paragraph 3.
Article 5Addressee
This Decision is addressed to the Kingdom of the Netherlands.
Done at Brussels, 22 November 2016.
For the Commission
Vytenis Andriukaitis
Member of the Commission